Eli Lilly and Company India Private Limited
Chennai, Tamil Nadu
Est. 2014
About Company
Description
Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.
Contact Information
Primary Phone
Primary Email
Website
Registered Address
Full Address
SIPCOT, Sriperumbudur
City
Chennai
State
Tamil Nadu
Pincode
602105
Country
India
Business Information
Business Types
Manufacturer
PCD Franchisor
Exporter
Year Established
2014
Manufacturing Units
1
Legal & Compliance
Certifications & Approvals
WHO-GMP
Certified
ISO
Not Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Not Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No
PCD/Franchise Information
PCD Franchisor
Yes
Products
Total products: 6
| Product Name | Dosage Form | Composition | Therapeutic Category |
|---|---|---|---|
| In October 2025, law enforcement in the UK shut down a facility manufacturing illicit counterfeit tirzepatide , seizing more than 2,000 fake injection pens in what is believed to be the world’s larges | Injection | - | - |
| In October 2025, law enforcement in the UK shut down a facility manufacturing illicit counterfeit tirzepatide , seizing more than 2,000 fake injection pens in what is believed to be the world’s larges | Injection | - | - |
| On May 21, 2024, the Australian government announced a complete ban on compounded tirzepatide and other compounded diabetes and weight loss medications due to the “increasing reports of patients comin | - | - | Antidiabetics |
| On May 21, 2024, the Australian government announced a complete ban on compounded tirzepatide and other compounded diabetes and weight loss medications due to the “increasing reports of patients comin | - | - | Antidiabetics |
| The FDA has explained that “poor compounding practices can result in serious drug quality problems, such as contamination,” which “can lead to serious patient injury and death.” The FDA has also obser | - | - | Dermatology |
| The FDA has explained that “poor compounding practices can result in serious drug quality problems, such as contamination,” which “can lead to serious patient injury and death.” The FDA has also obser | - | - | Dermatology |
Social Media
Company Status
Status
Active
Verification
Verified
Statistics
Profile Views
97
Total Inquiries
0